Research programme: pain therapeutics - Biogen/Inscopix
Latest Information Update: 28 Aug 2023
At a glance
- Originator Biogen; Inscopix
- Developer Biogen; Inscopix; Stanford University
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain